Trevi Therapeutics, Inc. - COM (TRVI)

Historical Portfolio Holders from Q2 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
55.9M
Holdings value Q2 2024
$167M
Value change Q2 2024
+$12.8M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
76
Number of buys Q2 2024
40
Number of sells Q2 2024
-23
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 59.9K $200K +$78K $3.34 2
2024 Q2 55.9M $167M +$12.8M $2.98 77
2024 Q1 51.6M $178M -$90.9K $3.45 79
2023 Q4 52.2M $70M -$4.02M $1.34 62
2023 Q3 48.7M $106M -$321K $2.18 55
2023 Q2 48.8M $117M +$12.8M $2.39 53
2023 Q1 43.5M $80.4M +$499K $1.85 35
2022 Q4 43.2M $83.3M -$3.85M $1.93 36
2022 Q3 45.8M $70.5M +$26.2M $1.54 37
2022 Q2 28.8M $80.8M +$28.7M $2.81 31
2022 Q1 7.16M $15.8M +$2.08M $2.20 20
2021 Q4 13.2M $10.3M -$219K $0.78 15
2021 Q3 12.4M $17.4M -$64K $1.40 15
2021 Q2 12.5M $28.1M -$1.75M $2.25 15
2021 Q1 13.1M $35.6M +$339K $2.71 17
2020 Q4 13M $31.7M -$645K $2.42 17
2020 Q3 13.3M $53.5M -$728K $4.03 13
2020 Q2 13.4M $88M -$1.32M $6.58 12
2020 Q1 14M $45.9M -$780K $3.29 17
2019 Q4 14.2M $53.2M -$141K $3.75 16
2019 Q3 14.1M $63.5M -$268K $4.50 17
2019 Q2 14.2M $106M +$106M $7.50 18